Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Testing Ranitidine With Too Much Heat Could Generate NDMA, FDA Says

Oct 02 2019

• By Malcolm Spicer

Research analyst adding reagent to drug to keep tracking chemical reaction - Image

Related Content

EMA Tells Firms To Evaluate OTCs For Carcinogenic Nitrosamines

Sep 27 2019

CVS, Walgreen Suspend OTC Ranitidine Sales As FDA Investigates Contamination

Sep 30 2019

Online Pharmacy Stirs Ranitidine Controversy With Petition To Halt Sales

Sep 15 2019

Related Companies

Novartis AG

Novartis AG

Sanofi

Additional Topics

United States Europe OTC Drugs Regulation FDA Advertising, Marketing & Sales Advisory Committees Clinical Trials Commercial Compliance Distribution Manufacturing Policy Safety Enforcement Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window